Peter Stoemmer has studied medicin at the university of Erlangen-Nuremberg, Germany and completed his MD, PhD and specialisation as general pathologist (including cytopathology and molecular pathology) at the age of 36 years) from Friedrich Alexander University Erlangen; after postdoctoral studies from Yale University School of Medicine in the laboratory of Juan Rosai and the supervision of A.B. He is the director and partner of Pathologie Augsburg, an independent Laboratory for surgical Pathology. He is senior lecturer and professor at the institute of pathology at the Friedrich Alexander university and published more than 125 papers in journals

Pathology

Dr. Young is a research scientist at PH Miracle Center. He is a member of the American Society of Microbiologists, the American Naturopathic Association, an honorary member of the Connecticut Holistic Health Association, the Presidents Council at Brigham Young University, a consultant for InnerLight, Inc. and pH Miracle, Inc., and an advisor to Dean Lawrence Carter at the Martin Luther King Chapel at Morehouse College.

Dr. Young has devoted his life to researching the true causes of "disease," subsequently developing "The New Biology™" to help people balance their life.

Graciela Ghirardi Awarded by the Council of Physicians of the Province of Córdoba. Certification for life, February 22, 2013 as “Specialist in Pathological Anatomy”. She was the Head of Pathology Anatomy at Hospital Córdoba Hospital for 13 years and she served as the President Gremial Hospital Córdoba for 3 Periods. She has Publication in book Poems "Sendas" in the year 2009.

Specialist in Pathology

Born in Milan, July 4, 1944. 1962-1968: School of Medicine, University of Milan. 1965-1968: Studied in Institute of General Pathology, University of Milan. 1968: M.D., magna cum laude, discussing an experimental thesis on the radiosensitizing properties of aliphatic aldehydes. 1969 to present: Several positions on faculty of Institute of General Pathology, University of Milan. 1971-1985: Associate Professor of General Pathology, Faculty of Medicine and Surgery, University of Milan. 1973-1985: Assistant to the Chairman of General Pathology, Faculty of Medicine and Surgery, University of Milan. 1975: NATO fellowship. 1976: He worked at the Institute of Biochemistry of the University of Helsinki (Finland). 1979: Invited speaker at the round table on “Polyamines and Neoplastic Growth” at the Gordon Conference on Polyamines in Andover, NH (USA). Writer of a review on “Polyamines in Mammalian Tumors” to be published in “Advances in Cancer Research”. 1981: Selected to Corresponding Membership of the American Association for Cancer Research. The cover of the April issue of The Journal of the National Cancer Institute has been entirely addressed to the paper on the circadian rithm of hepatic ornithine decarboxylase during hepatocancinogenesis in the rat. 1982: Invited speaker at 41° Bat Sheva Seminar on “Polyamines in Growth and Differentiation Processes” in Jerusalem (Israel). 1983: Invited speaker at the 12th NATO Course on “Pineal Gland and its Endocrine Role”, held in Erice (Italy). 1986 to present: Professor of General Pathology, Faculty of Medicine and Surgery, University of Milan. 1986: Invited speaker at the International Conferences on “Polyamines in Life Sciences” in Lake Yamanaka (Japan). 1986: Invited speaker and chairman at the International Meeting on Brain Oncology” held in Rennes (France). 1987: Organized of a International Meeting on “Polyamines in Biology and Medicine”, held in Milan (Italy). 1988: Invited speaker at the International Symposium on “Polyamines in Biochemical and Clinical Research”; held in Sorrento (Italy). 1993: Invited speaker at the International Symposium “Thomas Addison and Its Diseases: 200 Years on”, held in London (U.K.). 1996: Invited chairman at the Tokyo International Symposium on Polyamines, held in the Shoan Village Center (Japan). 1998 to 2004: Director of the Institute of General Pathology, Faculty of Medicine and Surgery, University of Milan. 2000 to 2006: Scientific Coordinator of the PhD course in “Experimental Pathology and Neuropathology” of the Faculty of Medicine and Surgery of the University of Milan. 2003: Invited speaker at the 3rd International Conference on Hyperhomocysteinemia, Saarbrücken, Germany. Invited speaker at the Symposium on “B12 and Multiple Sclerosis” for ECTRIMS (Milan). 2005: Invited speaker at the Gordon Research Conference on “Vitamin B12 and Corphins”, Oxford, U.K. Invited speaker at the 5th International Conference on Homocysteine Metabolism, Milan, Italy. 2006-2012: Director of the Post-graduate School of Biomedical Clinical and Experimental Sciences at the Faculty of Medicine and Surgery of the University of Milan. 2007: Invited speaker at ”The Global College of Neuroprotection and Neuroregeneration” (4th Annual Conference), Garmisch, Germany. 2008: Elected Corresponding Member of the “Istituto Lombardo – Accademia di Scienze e Lettere” (Milan, Italy). 2011: Member of the Editorial Board of “Chinese Journal of Clinicians” (Electronic Edition). 2012: Member of the Editorial Board of “Scientifica” (Neurology Section). Invited speaker and chairman at the “Advances and Controversies in B-Vitamins and Choline 2012” conference, Leipzig, Germany. Invited speaker at the “Vitamin B12 Symposium”, Nancy, France. -2013: Member of the Editorial Board of “World Journal of Meta-Analysis". Member of the Editorial Board of “Autoimmune Disease & Therapeutic Approaches: Open Access”. Member of the Editorial Board of “Journal of Blood Disords”.

Pathology, Clinical Pathology, neurobiology, oncology, and molecular biology

Qualifications: (1994), European Fellowship in Neuropathology (EuroCNS 1996), IUD of Neuropathology (1997), Doctor of Science in Life Sciences (1999), Dean of Biology of Aging ), Pathology of the Peripheral Nervous System (2002), DU of Molecular Biology (2002), HDR (2009), IUD of Fetal and Placental Pathology (2011), IUD of Medical Pedagogy 2013, EMAMH 2016 HOSPITAL AND UNIVERSITY TITLES AND FUNCTIONS • Professor of Universities-Hospital Practitioner in Pathological Anatomy and Cytology, Faculty of Medicine - Paris 7-Denis Diderot • Head of Department of Anatomy and Pathological Cytology of the Hôpital Lariboisière, APHP, Paris • Deputy Director of the Biological Resource Center, responsible for the Tissue Division (CRB-LRB) MAIN TEACHING ACTIVITIES • Coordination of the neurosensory module L3 • Creation and coordination of the IUD of Molecular Pathology in the Faculty of Medicine - Paris 7-Denis Diderot • Co-coordinator of the teaching of developmental neuropathology at the European Confederation of Neurolopathological Societies (Euro CNS) with Prof. Eleonora Aronica

Pathology, Anatomical Pathology

Marie-Pierre Junier’s interest in brain neoplasms developed as a natural extension of fundamental research studies aiming at deciphering the role of neuron-glia interactions during development and neurodegenerative diseases. Following studies of the role of troubles of glial cell differentiation in cancerous transformation, she created with Dr. H Chneiweiss the team “Glial plasticity and neuro-oncology” located in the Neuroscience laboratory of the Institute of Biology Paris Seine Institute (IBPS). The team project questions the dynamics of tumor cell functional heterogeneity, and its impact on malignant glioma growth.

Dr. Qing Kay Li is an associate professor of Departments of Pathology and Oncology at the Johns Hopkins University School of Medicine. She has the American Board of Pathology certification in anatomic and clinical pathology, and subspecialty certification in cytopathology. Her areas of clinical expertise include surgical pathology, cytopathology, and oncological pathology. Dr. Li is also a faculty member and co-PI at the Johns Hopkins Biomarker Discovery Center. Her research interests is focusing on the application of advanced cellular and molecular techniques to the field of cytopathology and cancer biology, particularly in the field of early detection of lung and prostate cancer. Dr. Li serves as editorial board members for several journals; committee members of the American Society of Cytopathology, Papanicolaou Society of Cytopathology, NIH/NCI lung cancer and kidney cancer working group; study sections of government agents and private organizations. She has more than 120 publications, including several book chapters and books. She has served as a keynote speaker at national and international meetings.

surgical pathology, cytopathology, and oncological pathology

Zahra Maleki is an assistant professor of pathology at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include surgical pathology and cytopathology. Her priority as a clinician and pathologist is to serve the patients by performing both fine needle aspirations and on site evaluations of specimen adequacy, and providing an accurate, timely diagnosis. She teaches and mentors fellows, residents, and students at the Johns Hopkins School of Medicine. She received her medical degree from Shaheed Beheshti University of Medical Sciences and completed a residency in anatomic and clinical pathology at the Virginia Commonwealth University School of Medicine. She performed her first fellowship at the Virginia Commonwealth University School of Medicine in pathology and a second fellowship in cytopathology at the University of Miami.

Dr. Maleki's research interests include head/neck and lung neoplasms & Translational studies in lung neoplasms. She is investigating the role of human papilloma virus (HPV) in head and neck squamous cell carcinomas.

Peter Stoemmer has studied medicin at the university of Erlangen-Nuremberg, Germany and completed his MD, PhD and specialisation as general pathologist (including cytopathology and molecular pathology) at the age of 36 years) from Friedrich Alexander University Erlangen; after postdoctoral studies from Yale University School of Medicine in the laboratory of Juan Rosai and the supervision of A.B. He is the director and partner of Pathologie Augsburg, an independent Laboratory for surgical Pathology. He is senior lecturer and professor at the institute of pathology at the Friedrich Alexander university and published more than 125 papers in journals

Pathology

Maria Teresa Mascellino has completed her MD at the age of 25 years in Rome during the period of 1980 and specialization studies in Microbiology and Infectious Diseases from Sapienza University of Rome (Italy). She works as aggregate professor in the Department of Public Health and Infectious Diseases at Sapienza University of Rome. She is responsible of the Simple Operative Unit “Microbiological analyses in the immunocompromised hosts” and tutor of students and residents at the Department of Infectious Diseases. The main research field is actually the study of some microorganisms involved in human pathology focusing on MDR microorganisms such as KPC Klebsiella, Acinetobacter baumannii and Helicobacter pylori as well as Candida and on antibiotics activity. She has published other than 100 papers in reputed journals and has been serving as an editorial board member of repute. She is editor of the book “Bacterial and Mycotic infections in immunocompromised hosts: microbiological and clinical aspects” ISBN:978-1-63278-005-8. She is a reviewer for many important scientific international Journals and Research Projects from Ministry of University and Scientific Research. She has attended many national and international Conferences as speaker presenting relevant research topics. She is member of scientific societies as ESCMID, ASM, New York Academy of Science

Microbial Pathology

Graciela Ghirardi Awarded by the Council of Physicians of the Province of Córdoba. Certification for life, February 22, 2013 as “Specialist in Pathological Anatomy”. She was the Head of Pathology Anatomy at Hospital Córdoba Hospital for 13 years and she served as the President Gremial Hospital Córdoba for 3 Periods. She has Publication in book Poems "Sendas" in the year 2009.

Pathology

Dariusz Borys is an Associate Professor of Pathology and Orthopaedic Surgery, head of Orthopaedic and Pediatric Pathology and Director of Digital Pathology at Loyola University Chicago. He received his Doctor of Medicine from the University of Wroclaw, Poland in 1994 and completed a residency program in anatomic pathology at County General Hospital in Wroclaw, Poland in 1995. He completed his postdoctoral research at the University of Arizona, Tucson, Arizona in 1998. He continued on with and completed residency training in both anatomic pathology and clinical pathology at University of Illinois at Chicago in 2001. He received a Pediatric Pathology Fellowship at New York University, New York, New York in 2005 and followed that with an Orthopedic Pathology Fellowship at NYU Hospital for Joint Diseases, New York, New York in 2006. After completing his fellowships, Dr. Borys become faculty member in the rank of assistant professor at University of California and then he finally moved to Loyola University Chicago in 2013. At LUMC he is appointed as an Associate Professor of Pathology and Orthopaedic Surgery and is serving as the head of orthopaedic and pediatric pathology and director of digital pathology. Currently Dr. Borys' research focuses on the molecular markers in diagnostic, prognostic and targeted therapy in osteosarcoma.

orthopaedic and pediatric pathology, digital pathology

Dr. Antic is an Associate Professor and the Director of Cytopathology at the University of Chicago, USA. She is fellowship trained in genitourinary pathology and cytopathology at the MD Anderson Cancer Center and is a certified member of American Board of Pathology and Cytopathology. She oversees the Cytopathology Fellowship program at the University of Chicago and has mentored several fellows over the past several years. She is a member of the American Society of Clinical Pathology CheckPath Committee and the chair of American Society of Cytopathology Clinical Practice Committee. She has published over 70 research papers in various peer-reviewed top-rated journals including the American Journal of Surgical Pathology and Nature. In addition, she has written several book chapters and authored a book titled “Renal Neoplasms: an Integrative Approach to Cytopathologic Diagnosis” published in 2014. Dr. Antic’s research interest is in the area of kidney and urothelial carcinoma.

Genitourinary Pathology Cytopathology Head and Neck Pathology

Born in Milan, July 4, 1944. 1962-1968: School of Medicine, University of Milan. 1965-1968: Studied in Institute of General Pathology, University of Milan. 1968: M.D., magna cum laude, discussing an experimental thesis on the radiosensitizing properties of aliphatic aldehydes. 1969 to present: Several positions on faculty of Institute of General Pathology, University of Milan. 1971-1985: Associate Professor of General Pathology, Faculty of Medicine and Surgery, University of Milan. 1973-1985: Assistant to the Chairman of General Pathology, Faculty of Medicine and Surgery, University of Milan. 1975: NATO fellowship. 1976: He worked at the Institute of Biochemistry of the University of Helsinki (Finland). 1979: Invited speaker at the round table on “Polyamines and Neoplastic Growth” at the Gordon Conference on Polyamines in Andover, NH (USA). Writer of a review on “Polyamines in Mammalian Tumors” to be published in “Advances in Cancer Research”. 1981: Selected to Corresponding Membership of the American Association for Cancer Research. The cover of the April issue of The Journal of the National Cancer Institute has been entirely addressed to the paper on the circadian rithm of hepatic ornithine decarboxylase during hepatocancinogenesis in the rat. 1982: Invited speaker at 41° Bat Sheva Seminar on “Polyamines in Growth and Differentiation Processes” in Jerusalem (Israel). 1983: Invited speaker at the 12th NATO Course on “Pineal Gland and its Endocrine Role”, held in Erice (Italy). 1986 to present: Professor of General Pathology, Faculty of Medicine and Surgery, University of Milan. 1986: Invited speaker at the International Conferences on “Polyamines in Life Sciences” in Lake Yamanaka (Japan). 1986: Invited speaker and chairman at the International Meeting on Brain Oncology” held in Rennes (France). 1987: Organized of a International Meeting on “Polyamines in Biology and Medicine”, held in Milan (Italy). 1988: Invited speaker at the International Symposium on “Polyamines in Biochemical and Clinical Research”; held in Sorrento (Italy). 1993: Invited speaker at the International Symposium “Thomas Addison and Its Diseases: 200 Years on”, held in London (U.K.). 1996: Invited chairman at the Tokyo International Symposium on Polyamines, held in the Shoan Village Center (Japan). 1998 to 2004: Director of the Institute of General Pathology, Faculty of Medicine and Surgery, University of Milan. 2000 to 2006: Scientific Coordinator of the PhD course in “Experimental Pathology and Neuropathology” of the Faculty of Medicine and Surgery of the University of Milan. 2003: Invited speaker at the 3rd International Conference on Hyperhomocysteinemia, Saarbrücken, Germany. Invited speaker at the Symposium on “B12 and Multiple Sclerosis” for ECTRIMS (Milan). 2005: Invited speaker at the Gordon Research Conference on “Vitamin B12 and Corphins”, Oxford, U.K. Invited speaker at the 5th International Conference on Homocysteine Metabolism, Milan, Italy. 2006-2012: Director of the Post-graduate School of Biomedical Clinical and Experimental Sciences at the Faculty of Medicine and Surgery of the University of Milan. 2007: Invited speaker at ”The Global College of Neuroprotection and Neuroregeneration” (4th Annual Conference), Garmisch, Germany. 2008: Elected Corresponding Member of the “Istituto Lombardo – Accademia di Scienze e Lettere” (Milan, Italy). 2011: Member of the Editorial Board of “Chinese Journal of Clinicians” (Electronic Edition). 2012: Member of the Editorial Board of “Scientifica” (Neurology Section). Invited speaker and chairman at the “Advances and Controversies in B-Vitamins and Choline 2012” conference, Leipzig, Germany. Invited speaker at the “Vitamin B12 Symposium”, Nancy, France. -2013: Member of the Editorial Board of “World Journal of Meta-Analysis". Member of the Editorial Board of “Autoimmune Disease & Therapeutic Approaches: Open Access”. Member of the Editorial Board of “Journal of Blood Disords”.

Pathology, Clinical Pathology, neurobiology, oncology, and molecular biology.

•Joined as a Faculty member (as Assistant Professor) at MAMC, after completing training (DNB) in Nephrology at AIIMS New Delhi since 1990 •National team of trainers on AIDS, under NACO-WHO project in 1993 •Faculty member and Consultant Nephrologist at International Islamic University Kuantan, Malaysia – 1998-2002 •Faculty Incharge- Nephrology, Deptt Of Medicine MAMC&LNH -1997 and as a Professor since 1998- 2008 •WHO fellowship in Community Health Care Research in 2007 •Director Professor (2008-09) and currently Head of the Medicine De Dr partment since Sept 2016 •Created Deptt. Of Nephrology -2016 •Published many scientific paper in International and National journal and have been guiding post graduate students in medicine for their thesis since 1992 •He is a active member of Indian society of nephrology , association of physician of India and International society of Nephrology

Nephrology, Clinical Pathology

Dr. Holladay serves as the American Society for Clinical Pathology (ASCP) Chief Executive Officer. He has focused on globalization initiatives for the medical laboratory community that include significant contributions to the President’s Emergency Plan for AIDS Relief (PEPFAR) funded through the Centers for Disease Control and Prevention; strategic partnerships in laboratory medicine; corporate reorganization/management activities; mergers and acquisitions; international outreach; external partnerships; and health services research and delivery. ASCP has been funded for over $40 million to support patient-centered care. His scientific research work focuses in the areas of cytopathology and molecular research. He’s been funded as a Principal Investigator for 50 scientific research grants and 100 scientific corporate contracts. He has published a number of significant research articles within the profession and is the primary author of several textbooks that are international best sellers. He is an active scientific lecturer and has given over 170 national and international speeches.

Pathology, Clinical Pathology

Qihui (Jim) Zhai is currently working as a Professor of Laboratory Medicine and Pathology College of Medicine, Mayo Clinic. He obtained his medical degree from Shandong Medical University, China. He is honoured as Top Pathologists by Consumer’s Research Council of America. He has published more than 100 works in peer reviewed journals. His research interest includes pathology and cancer.

Pathology

Victor Tron is currently working as a professor at university of Toronto. He has completed his medical education at University of Alberta, Edmonton in 1982. He has chaired many national & international meetings and served as member for Associations. Currently he is associated with Canadian Associations of Pathologists. He is also an editorial board member journal of Cutaneous Medicine and Surgery.

Pathology

Carol Apt received her Ph.D. in Sociology from Northeastern University in Boston, Massachusetts (USA), her M.A. in Sociology from Boston University in Boston, Massachusetts (USA), and her B.A. in Sociology from Indiana University in Indianapolis, Indiana. She also has a Certificate of French Studies from Ecole Lemania in Lausanne, Switzerland. Dr. Apt is currently a Professor of Sociology at South Carolina State University in Orangeburg, South Carolina, where she has been for the last 15 years. During that time she has taught Medical Sociology, Human Sexuality, Cultural Anthropology, Social Problems, and the Sociology of Genocide, among others. She is also a member of the South Carolina Medical Association Bioethics Committee and the Ethics Committee of The Regional Medical Center in Orangeburg, South Carolina. In addition, Dr. Apt is the host of a live, call-in radio talk show called ‘Talk to Me,’ which is broadcast on 90.3 FM-WSSB, also in Orangeburg. During her show she addresses listeners’ questions about sexuality and relationships.

Sociology

Sergey V Brodsky has completed his MD and PhD in 1992 and 1995, perspectively from North Ossetian Medical Academy in Russia. His research interests include renal pathology, renal physiology, vascular biology and angiogenesis. After finishing a residency in anatomic pathology and a fellowship in renal pathology in 2009, he currently works as a renal pathologist at the OSU. He has published more than 95 papers in peer-reviewed journals and book chapters

Renal Pathology & Renal Physiology

Reinhard Büttner is Professor and Chairman of The Institute of Pathology at University Hospital Cologne, Köln, Germany, and the Co-Founder and Chief Scientific Officer of TARGOS Molecular Diagnostics. He completed his medical degree at the University of Mainz, Mainz, Germany, in 1985, before starting a residency at Rheinisch-Westfalische Technische Hochschule RWTH Aachen, Aachen, Germany. In 1987, he began post-doctoral work at the Gene Centre Munich and MD Anderson Cancer Centre, Houston, TX, USA (1987‒1990). Returning to Germany in 1991, he took up a residency at the University of Regensburg, before becoming Professor and Chairman for Pathology at RWTH Aachen (1999‒2001). After which, he worked as a Professor and Chairman of Pathology at the University of Bonn (2001‒2011), before being appointed to his current position as Professor and Chairman of Pathology at the University of Cologne in 2011. Reinhard Büttner specialises in molecular pathology and is a member of a number of academic societies including the German Society of Pathology and the International Academy of Pathology. He is the Co-President of the International Academy of Pathology World Congress of Pathology, Cologne 2016. He has more than 450 peer-reviewed papers published in high-impact internationally renowned journals.

molecular pathology

Dr. Luo has been studying molecular pathology related to human malignancies in the last 24 years. Currently, he is a Professor of Pathology and Director of High Throughput Genome Center at University of Pittsburgh. In the last 16 years, Dr. Luo has been largely focusing on genetic and molecular mechanism of human prostate cancer and hepatocellular carcinomas. In this period, his group has identified and characterized several genes that are related to prostate cancer and hepatocellular carcinoma, including SAPC, myopodin, CSR1, GPx3, ITGA7, MCM7, MT1h and GPC3. He has characterized several signaling pathways that play critical role in prostate cancer development, including Myopodin-ILK-MCM7 inhibitory signaling, myopodin-zyxin motility inhibition pathway, CSR1-CPSF3, CSR1-SF3A3 and CSR1-XIAP apoptotic pathways, MT1h-EHMT1 egigenomic signaling, ITGA7-HtrA2 tumor suppression pathway, GPx3-PIG3 cell death pathway, AR-MCM7 and MCM7-SF3B3 oncogenic pathways. He proposed prostate cancer field effect in 2002. He is one of the pioneers in utilizing high throughput gene expression and genome analyses to analyze field effects in prostate cancer and liver cancer. He is also the first in using methylation array and whole genome methylation sequencing to analyze prostate cancer. Recently, Dr. Luo’s group found that patterns of copy number variants of certain specific genome loci are predictive of prostate cancer clinical outcomes, regardless tissue origin. His discovery of several novel fusion transcripts and their association with aggressive prostate cancer has brought significant new insight into the field of prostate cancer research. Overall, these findings advance our understanding on how cancer develops and behaves, and lay down the foundation for better future diagnosis and treatment of human malignancies

Dr. Luo has been largely focusing on genetic and molecular mechanism of human prostate cancer and hepatocellular carcinomas. In this period, his group has identified and characterized several genes that are related to prostate cancer and hepatocellular carcinoma, including SAPC, myopodin, CSR1, GPx3, ITGA7, MCM7, MT1h and GPC3. He has characterized several signaling pathways that play critical role in prostate cancer development, including Myopodin-ILK-MCM7 inhibitory signaling, myopodin-zyxin motility inhibition pathway, CSR1-CPSF3, CSR1-SF3A3 and CSR1-XIAP apoptotic pathways, MT1h-EHMT1 egigenomic signaling, ITGA7-HtrA2 tumor suppression pathway, GPx3-PIG3 cell death pathway, AR-MCM7 and MCM7-SF3B3 oncogenic pathways.

Dr. Liang Cheng is Virgil H. Moon Endowed Professor of Pathology and Urology at Indiana University School of Medicine, Indianapolis, Indiana, USA. Currently, he is Chief of the Genitourinary Pathology Service, Director of the Urologic Pathology Fellowship, and Director of Molecular Diagnostics and Molecular Pathology Laboratories. Dr. Cheng is board certified in Molecular Genetic Pathology, Anatomic and Clinical Pathology by the American Board of Pathology. Dr. Cheng has received numerous prestigious awards including the Stowell-Orbison Award from the United States and Canadian Academy of Pathology (USCAP) and the Koss Medal Award from the International Society of Urological Pathology (ISUP). Dr. Cheng received the Arthur Purdy Stout Prize from the Arthur Purdy Stout Society of Surgical Pathologists in recognition of outstanding contributions to the field of surgical pathology for a surgical pathologist less than 45 years old. Dr. Cheng has published over 780 peer-reviewed SCI articles in high-impact scientific journals. His published work has been cited more than 30,000 times (ISI Web of Science h-index: 87). He is also the author of over 80 book chapters and several books, including Bladder Pathology, Urologic Surgical Pathology, Essentials of Anatomic Pathology, Molecular Genetic Pathology, Atlas of Genitourinary Pathology, Molecular Surgical Pathology, Rare Tumors and Tumor-like Conditions, Pathology of the Urinary Bladder-An Algorithmic Approach, and Atlas of Anatomic Pathology (Series Editor). Currently, he is an active member of over 30 Editorial Boards, including Molecular Cancer (Associate Editor), Human Pathology (Senior Associate Editor), American Journal of Surgical Pathology, Modern Pathology, Histopathology, Journal of Pathology, Journal of Clinical Pathology, European Journal of Cancer, Pathology, Future Oncology, Urologic Oncology, Expert Review of Anticancer Therapy, Critical Reviews in Oncology/Hematology and others. In 2015, Dr. Cheng was ranked among the Top 10 World’s Experts in Urogenital Neoplasms, and No. 5 in the field of Bladder Cancer by Expertscape (http://www.expertscape.com/leaders/bladder-cancer). Dr. Cheng's research focuses on translational studies of genitourinary cancers and molecular diagnostics of solid tumors.

Bladder Pathology, Urologic Surgical Pathology, Essentials of Anatomic Pathology, Molecular Genetic Pathology

Graduated in Pharmacy at the Federal University of Rio de Janeiro, PhD in Sciences at the Federal University of Rio de Janeiro. He is currently professor at the Federal University of Santa Catarina and coordinates the Stem Cell and Bioengineering Laboratory. The Laboratory investigates the role of mesenchymal stem cells in the repair of neural injury as well as bone regeneration. Three-dimensional scaffolds for cultivation and maintenance of mesenchymal stem cells are one of the lines of research of the Stem Cell and Bioengineering Laboratory. The Laboratory also investigates how mesenchymal stem cells can act as support for the ex vivo expansion of hematopoietic stem cells. The Stem Cell and Bioengineering Laboratory evaluates how amplification of hematopoietic stem cell can target allogeneic hematopoietic stem cell transplantation.

1.Neuronal regeneration in stroke; 2.Stem Cells; 3.Scaffolds for bone tissue engineering; 4.Amplification ex vivo of hematopoietic stem cells; 5.Leukemia and lymphoma.